Dogansen, Sema Ciftci Cikrikcili, Ugur Oruk, Gonca Kutbay, Nilufer Ozdemir Tanrikulu, Seher Hekimsoy, Zeliha Hadzalic, Aysa Gorar, Suheyla Omma, Tulay Mert, Meral
...
Published in
The Journal of clinical endocrinology and metabolism
Dopamine agonist (DA)-induced impulse control disorder (ICD) in patients with prolactinomas is not sufficiently known. To evaluate the prevalence of DA-induced ICDs and possible risk factors related to these disorders in patients with prolactinoma. This is a cross-sectional multicenter study involving 308 patients with prolactinoma followed up in t...
Aulinas, Anna Pulumo, Reitumetse L Asanza, Elisa Mancuso, Christopher J Slattery, Meghan Tolley, Christiane Plessow, Franziska Thomas, Jennifer J Eddy, Kamryn T Miller, Karen K
...
Published in
The Journal of Clinical Endocrinology & Metabolism
Oxytocin regulates a range of physiological processes including eating behavior and oxytocin administration reduces caloric intake in males. There are few data on oxytocin and eating behavior in healthy females or on the response of endogenous oxytocin to food intake and its relationship to appetite in humans. To determine the postprandial pattern ...
Leder, Benjamin Z O'Dea, Louis St L Zanchetta, José R Kumar, Prasana Banks, Kathleen McKay, Kathleen Lyttle, C Richard Hattersley, Gary
Published in
The Journal of Clinical Endocrinology & Metabolism
Compared with placebo, 24 weeks of daily sc abaloparatide increases BMD of the lumbar spine, femoral neck, and total hip in a dose-dependent fashion. Moreover, the abaloparatide-induced BMD increases at the total hip are greater than with the marketed dose of teriparatide. These results support the further investigation of abaloparatide as an anabo...
Marazuela, M Paniagua, A E Gahete, M D Lucas, T Alvarez-Escolá, C Manzanares, R Cameselle-Teijeiro, J Luque-Ramirez, M Luque, R M Fernandez-Rodriguez, E
...
Published in
The Journal of Clinical Endocrinology & Metabolism
No previous radiotherapy, shorter duration of prepegvisomant somatostatin analog therapy, and higher tumor expression of GH and insulin receptor could be risk factors for tumor growth during pegvisomant therapy.
Kaufman, Jean-Marc Ostertag, Agnès Saint-Pierre, Aude Martine Cohen-Solal Boland, Anne Van Pottelbergh, Inge Toye, Kaatje de Vernejoul, Marie-Christine Martinez, Maria
Published in
The Journal of Clinical Endocrinology & Metabolism
Context: Bone mass is under strong genetic control, with heritability estimates greater than 50% and is likely determined by complex interactions between genetic and environmental factors.
Objective: The objective of the study was to localize genes contributing to bone mineral density (BMD) variation.
Design: An autosomal genome-wide scan for...
Huang, Yu-Yao Yu, Zhenkun Lin, Shu-Fu Li, Sen Fong, Yuman Wong, Richard J
Published in
The Journal of Clinical Endocrinology & Metabolism
NV1023 causes significant cytotoxicity of anaplastic, medullary, and papillary thyroid cancers. Nectin-1 is a novel marker of thyroid cancer sensitivity to herpes oncolytic therapy that might guide patient selection for therapy.
Modan-Moses, Dalit Stein, Daniel Pariente, Clara Yaroslavsky, Amit Ram, Anka Faigin, Michal Loewenthal, Ron Yissachar, Eleanor Hemi, Rina Kanety, Hannah
...
Published in
The Journal of Clinical Endocrinology & Metabolism
Our study demonstrates hyperadiponectinemia, increased adiponectin HMW isoform, and increased insulin sensitivity in adolescent AN female patients and reversal of these findings with weight rehabilitation. We hypothesize that increased adiponectin levels may have a protective role in maintaining energy homeostasis during extreme malnourishment.
Balas, Bogdan Baig, Muhammad R Watson, Catherine Dunning, Beth E Ligueros-Saylan, Monica Wang, Yibin He, Yan-Ling Darland, Celia Holst, Jens J Deacon, Carolyn F
...
Published in
The Journal of Clinical Endocrinology & Metabolism
During MTT, vildagliptin augments insulin secretion and inhibits glucagon release, leading to enhanced suppression of EGP. During the postprandial period, a single dose of vildagliptin reduced plasma glucose levels by enhancing suppression of EGP.
Cust, Anne E Kaaks, Rudolf Friedenreich, Christine Bonnet, Fabrice Laville, Martine Lukanova, Annekatrin Rinaldi, Sabina Dossus, Laure Slimani, Nadia Lundin, Eva
...
Published in
The Journal of Clinical Endocrinology & Metabolism
High circulating adiponectin levels are associated with reduced endometrial cancer risk, largely independent of other obesity-related risk factors.
Sawka, A M Aniszewski, J P Young, W F Jr Nippoldt, T B Yanez, P Ebersold, M J
Published in
The Journal of Clinical Endocrinology & Metabolism
We describe four cases of symptomatic pneumocranium, a rare, potentially life-threatening complication of transsphenoidal pituitary surgery. Symptomatic pneumocranium manifested as impaired mental status, headaches, and grand mal seizures, early in the postoperative course after transsphenoidal pituitary surgery. Furthermore, a Cushing response, in...
